BlackRock Health Sciences Opportunities Portfolio Investor C Shares (SHSCX)

Fund Assets	6.09B
Expense Ratio	1.86%
Min. Investment	$1,000
Turnover	43.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	49.52
YTD Return	13.98%
1-Year Return	30.55%
5-Year Return	30.71%
52-Week Low	45.14
52-Week High	54.27
Beta (5Y)	0.69
Holdings	159
Inception Date	Oct 16, 2000

About SHSCX

The BlackRock Health Sciences Opportunities Fund Investor C Shares is a mutual fund focused on equity investments within the health sciences sector. Its primary objective is to invest at least 80% of its assets in the common stock of companies involved in health sciences and related industries. This includes businesses operating in health care equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. The fund seeks to offer diversified exposure to both growth and value stocks across these healthcare-related segments, including opportunities in non-U.S. markets. With a track record dating back to 2000 and total assets exceeding $7.5 billion, the fund has established itself as a notable player in the sector, aiming to deliver returns with lower volatility compared to its peers. It holds around 145 individual securities and is managed by BlackRock’s specialized healthcare team, leveraging scientific expertise alongside financial analysis to identify compelling investment opportunities. The fund is recognized for its sector-specific focus and its role in providing investors broad access to the innovation-driven health sciences industry.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Low
• Stock Exchange: NASDAQ
• Ticker Symbol: SHSCX
• Share Class: Investor C
• Index: Russell 3000 Healthcare TR

Performance

SHSCX had a total return of 30.55% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.38%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSSX	Institutional	0.84%
SHSAX	Investor A	1.09%
SHISX	Service	1.14%

Top 10 Holdings

53.00% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.68%
Johnson & Johnson	JNJ	7.87%
UnitedHealth Group Incorporated	UNH	6.34%
Merck & Co., Inc.	MRK	5.26%
AbbVie Inc.	ABBV	5.11%
Gilead Sciences, Inc.	GILD	3.74%
Amgen Inc.	AMGN	3.44%
Thermo Fisher Scientific Inc.	TMO	3.18%
Vertex Pharmaceuticals Incorporated	VRTX	2.89%
Edwards Lifesciences Corporation	EW	2.49%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$2.85576	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.09215	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$0.99992	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 26, 2026

Data Sources Report a data error